Skip to content
Arcadia Biosciences logo

Arcadia Biosciences

RKDA

Arcadia Biosciences is a consumer goods company focused on the production and distribution of plant-based beverage products.

Market cap
$1.39M-75.8%

Table of contents

Earnings

Next report

Aug 19, 2026 (In 3 weeks)
Revenue estimate$1.9M
EPS estimate-$0.56

Competitors

Profile

Arcadia Biosciences is a consumer goods company focused on the production and distribution of plant-based beverage products. The company primarily markets premium coconut water through its flagship brand, leveraging a supply chain sourced from Thailand to provide natural hydration products to the U.S. market. Following a strategic pivot, the company has monetized its legacy agricultural biotechnology assets through divestitures and licensing agreements.

Competitive position

Arcadia is a niche player in the functional beverage market, transitioning from a science-heavy biotech firm to a lean, brand-focused consumer goods entity.

GeographiesUnited States, Thailand
Customer segmentsRetail, Wholesale
Business modelConsumer Packaged Goods (CPG), IP Licensing
SuppliersThai coconut growers, Packaging providers in Thailand, Customs brokers, Logistics partners
CustomersRetail grocery chains, Foodservice providers, End-market consumers
Listed2015
Employees21.0
CEOThomas J. Schaefer
FilingsSEC EDGAR

Questions, answered.

What is Arcadia Biosciences's market cap?
Arcadia Biosciences (RKDA) has a market capitalization of $1.4M and trades on NASDAQ.
Who are Arcadia Biosciences's competitors?
Arcadia Biosciences's key competitors include The Vita Coco Company, National Beverage Corp., PepsiCo, Inc., and others. These companies compete in similar markets and product categories.
Who does Arcadia Biosciences partner with?
Arcadia Biosciences's notable partners include Corteva Agriscience, Above Food, Bioceres Crop Solutions Corp., and others.
What subsidiaries does Arcadia Biosciences have?
Arcadia Biosciences's subsidiaries include Zola.
Where is Arcadia Biosciences headquartered?
Arcadia Biosciences is headquartered in United States of America and employs approximately 21 people. It has been publicly traded since 2015.